Abstract
The efficacy of microwave ablation is mainly determined by preablation tumor size and location in relation to the hilum. PurposeTo prospectively evaluate the safety and efficacy of microwave ablation therapy of unresectable pulmonary metastases.Materials and MethodsAll patients provided informed consent for this prospective institutional review board–approved study. Eighty patients (30 men, 50 women; mean age, 59.7 years ± 6.4; range, 48–68 years) underwent computed tomography–guided percutaneous microwave ablation of pulmonary metastatic lesions in 130 sessions. The tumors represented metastases from colorectal carcinoma, breast carcinoma, hepatocellular carcinoma, renal cell carcinoma, and bronchogenic carcinoma; there was no evidence of extrapulmonary metastasis for any tumor. Logistic regression analysis was used for evaluation of the statistical significance of factors affecting the end result of microwave ablation therapy. The Kaplan-Meier method was used for estimation of survival rates.ResultsComplete, successful ablation was achieved in 95 (73.1%) of 130 lesions. Successful tumor ablation was significantly more fre...

This publication has 26 references indexed in Scilit: